To amend title XXVII of the Public Health Service Act, the Employee Retirement Income Security Act of 1974, and the Internal Revenue Code of 1986 to require the displaying of claim denial rates.
Summary
HR9396, introduced by Rep. Goldman (R-TX), would require health insurers to publicly display claim denial rates. The bill is in early legislative stages with referral to three committees. For retail investors, no material near-term impact on health insurer stocks ($UNH) is expected, as compliance costs are negligible relative to revenue.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.HR9396 is an early-stage bill with low probability of near-term passage.
- 2.The requirement to disclose claim denial rates imposes modest compliance costs on health insurers.
- 3.No direct financial impact on $UNH or other insurers at this stage; investors should monitor committee activity.
Market Implications
No immediate implications for healthcare stocks. If the bill advances, it could slightly increase operational costs for insurers like UnitedHealth Group, Elevance Health ($ELV), Humana ($HUM), and Cigna ($CI), but the effect would be negligible compared to revenue. The transparency could lead to regulatory or reputational pressure, but not near-term.
Full Analysis
HR9396 was introduced on June 23, 2026 and referred to the House Committees on Energy and Commerce, Ways and Means, and Education and Workforce. The bill amends the Public Health Service Act, ERISA, and the Internal Revenue Code to mandate that health insurance issuers and group health plans display their claim denial rates. This is a transparency measure that does not alter coverage requirements or pricing. At this early stage — introduced and referred — the likelihood of passage is low. Even if enacted, the compliance burden on large insurers like UnitedHealth Group (UnitedHealthcare) is minimal; tracking and publishing denial rates is an incremental administrative task. No funding is authorized or appropriated. The bill's sponsor is a junior member (Rep. Goldman, R-TX), which further reduces near-term momentum. Structural winners: none. Losers: insurers with high denial rates could face reputational scrutiny, but this is speculative. Timeline: committee consideration likely in 2026-2027 if it advances.
Key Legislators
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Enhancing Program Integrity and Integrity and Interagency Coordination in the Administration of the H-1B Nonimmigrant Visa Program
This executive order directs the Secretaries of State, Labor, and Homeland Security to coordinate with Commerce, Education, and the SBA when processing H-1B petitions, and requires them to consider whether the employer has engaged in layoffs of similarly situated U.S. workers within the past year. It also orders the Labor Department to review past labor condition applications for potential enforcement actions against sponsoring employers, effectively tightening scrutiny on H-1B usage, especially by outsourcing firms.
Accelerating Access To Veterans' Benefits And Employment Opportunities
This proclamation orders the Secretaries of War and Veterans Affairs to mandate rapid, ongoing digital sharing of military personnel and medical records, deploy AI-powered tools for benefits applications, and update existing IT contracts for interoperability. It also requires the Transition Assistance Program to connect separating service members to specific jobs or training programs before discharge.
Delivering Gold Standard Childhood Vaccine Recommendations for Americans
This executive order directs HHS to establish a 'Gold Standard' childhood vaccine schedule with fewer recommended vaccines than current CDC guidelines, mandates that MMR be administered as three separate single-disease shots when domestically available, and instructs the DOJ to challenge state vaccine mandates that do not provide religious or medical exemptions. It also orders HHS to develop alternative adjuvants to aluminum and improve vaccine safety monitoring, while preserving access to existing vaccines.
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →